Core Viewpoint - Abacus Global Management, Inc. is facing significant scrutiny and a decline in share price due to allegations of improper accounting practices, as detailed in two critical reports from Morpheus Research within a week [1][3][5]. Group 1: Allegations and Reports - Morpheus Research published an initial report on June 4, 2025, alleging that Abacus engaged in an "accounting scheme" by using "mark-to-model" accounting and underestimating life expectancies, leading to the creation of "fake revenue" [3][4]. - The second report from Morpheus, released on June 12, 2025, escalated the allegations by presenting new evidence of undisclosed related-party dealings and questioning the independence of the actuarial firm Lewis & Ellis, which Abacus claimed had vetted its asset valuations [5][6]. Group 2: Market Reaction - Following the initial Morpheus report, Abacus's shares experienced a decline of over 20% in a single trading day [4]. - The ongoing investigations and negative reports have led to a continued sharp decline in Abacus's share price, raising concerns among investors [6]. Group 3: Company Response - In response to the allegations, Abacus published a rebuttal on June 10, 2025, asserting that it had retained Lewis & Ellis to validate its balance sheet, claiming the firm has a "sterling reputation" [4]. - However, Morpheus's follow-up report indicated that Abacus's rebuttal was inadequate and contradicted its own SEC filings, further intensifying scrutiny on the company's financial practices [5].
Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman